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Introduction
Diabetes has been recently associated with urinary
tract infections.1 The mechanism of  pathogenesis for
this association is not fully elucidated, however, it is
suggested that high glucose concentration in urine
may favour the growth of pathogenic
microorganisms.2 Asymptomatic bacteriuria is a form
of UTI characterized by the presence of significant
amount (>105 cfu/ml) of bacteria in urine.3,4
Several studies have documented the
association of ASB with diabetes; however, reports
on the prevalence of  ASB appear contradictory.
Asymptomatic bacteriuria in diabetes mellitus patients in Southwest
Cameroon
Marie E. A. Bissong1*, Peter N. Fon2, Fritz O. Tabe-Besong3 and Theresa N. Akenji1
1. Department of  Microbiology and Parasitology, Faculty of  Science, University of  Buea, Cameroon
2. Department of Public Health, Faculty of Health Sciences, University of Buea, Cameroon
3. Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Cameroon
Abstract
Background: Asymptomatic bacteriuria (ASB) is common in diabetics and predisposes these patients to more severe
urinary tract infections (UTIs). Reports on the prevalence and etiology of ASB especially in developing countries appear
contradictory.
Objectives: To determine the prevalence and etiology of  ASB and antimicrobial resistance of  urinary isolates in diabetics
and non-diabetics.
Methods: The study involved a total of 265 participants including 154 diabetes mellitus patients and 111 non-diabetics in
Southwest Cameroon. Mid-stream urine was collected from consented subjects and each sample tested using the dipstick,
microscopy and culture techniques. Isolates were identified using standard biochemical tests.
Results: ASB was detected in 33.2% of participants; 38.3% in diabetics and 26.1% in non-diabetics (P = 0.03). Coagulase-
negative staphylococci (CNS) were the predominant organisms (36.3%) isolated from urine in both diabetics and non-
diabetics. Other isolates included Klebsiella sp (15.9%), Candida sp (13.7%), E. coli (10.8%) and Serratia sp (10.8%). Candida
sp was isolated more from diabetics than non-diabetics (P = 0.01).  There was no significant difference in resistance between
diabetics and non-diabetics (P > 0.05). Most isolates showed multiple resistance and ciprofloxacin was the most active
ingredient against bacterial uropathogens.
Conclusion: The study revealed a high prevalence of ASB in diabetics than in non-diabetics. A change in the aetiologic
spectrum was observed with Staphylococcus sp accounting for majority of  ASB. Most isolates showed multiple resistance in
both diabetics and non-diabetics; therefore the need to speed up sensitization against antibiotic abuse in Southwest
Cameroon.
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Most studies reported the prevalence to be higher in
people with diabetes than people without diabetes.5,6,7
On the contrary, another study8 reported no
significant difference in the prevalence of ASB
between diabetic women and non-diabetic women
(P = 0.07).
In the Netherlands, a prevalence of 26%
among women with diabetes compared to 6% in
non-diabetic women was reported.9 ASB was also
reported in 13.7 % of  diabetic women in Tanzania4;
20 % in Iran and 36.2 % in Nigeria.7,10 The variations
have been attributed to differences in the screening
test, geographical region and ethnicity.11 The most
frequently isolated uropathogens include Escherichia
coli, Klebsiella pneumoniae, Streptococcus agalactiae,
Enterococcus faecalis, coagulase negative Staphylococcus
and Streptococcus pyogenes.3,4,5 Although E. coli is known
to be the most common uropathogen, other
microorganisms are emerging with predominance
in cases of  ASB.
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Report from previous study noted a changing
pattern of ASB with Klebsiella sp accounting for the majority
(42.4%) of asymptomatic bacteriuria among diabetics.3
Another recent study in Nigeria reported Staphylococcus
aureus to be the most common uropathogen isolated from
both diabetics and non-diabetics with ASB.12 Antibiotic
resistance of uro-pathogens is increasingly being reported
with high occurrence of multiple drug resistant strains.3,5,10
Ciprofloxacin has been shown to be effective against most
urinary isolates.4,10 An increase in the trend of diabetes in
Cameroon was postulated some five years ago13 and in the
same setting, recent studies have reported high resistance
to commonly used antibiotics.14,15 Although ASB is a major
concern in diabetics, there is little information on the
occurrence of  ASB among diabetics in our local setting.
Thus, the current study is aimed at investigating the
prevalence and aetiology of ASB and antimicrobial resistant
pattern of urinary isolates in diabetic and non-diabetic
persons in Southwest Cameroon.
Methods
A total of 265 participants were enrolled into the study
including 154 diabetic patients and 111 non-diabetics.
Diabetic patients were enrolled into the study during their
regular visits at clinics in three hospitals in Southwest Region,
Cameroon. Non-diabetics were healthy individuals
recruited from the general population during a free diabetic/
hypertension screening campaign. Criteria for inclusion were
age > 18 years; history of diabetes for diabetics and no
diabetes for non-diabetics. Exclusion criteria included
pregnancy; history of any underlying illness; signs and
symptoms of UTI and antibiotic/antimicotic usage within
one week. Diabetic status was further confirmed using IDF
standards; diabetes (FBS > 126mg/dl and or the use of
hypoglycemic drugs). Ethical clearance was obtained from
the Regional Delegation for Public Health and the
University of Buea Institutional Review Board. A
questionnaire was administered to collect demographic and
clinical data from participants and specimens were collected
only from consented subjects.
The study participants were educated on how to
collect a “clean-catch” midstream urine specimen and the
importance to avoid contamination. They were advised on
washing of hands prior to collection and labia separation,
especially in females. Participants who had difficulties
collecting their specimens were assisted by trained
personnel. Urine samples were collected into sterile
containers, placed in a cool box (4oC) and transported to
the laboratory within 2 hours. The samples were then stored
in a refrigerator and analysed within 8 hours of collection.
Each sample was separated into two parts under sterile
conditions; one part for urinalysis and the other for culture.
The dip stick test was performed using urine test strips as
described by the manufacturer (Condor-Teco, Beijing,
China). Wet preparation of  centrifuged urine was observed
using 40 times objective lens to detect blood, pus and other
cells. A calibrated 10µl wire loop was used to inoculate un-
centrifuged urine into MacConkey, blood and Sabouraud’s
agar (BioMerieux, Marcy l’Etoile, France) and plates
incubated aerobically at 37oC for 24 hours. Significant ASB
was defined as urine culture of > 105 cfu/ml without
symptoms of cystitis.3 Isolates were identified using
standard biochemical techniques.16
Antimicrobial susceptibility testing was done by
the Kirby Bauer disk diffusion method using standard
procedures.16 Disks of commonly used drugs against
yeasts, Gram positive and negative organisms were selected.
These included; nalidixic acid, nitrofurantoin, ceftriaxone,
cefuroxime, doxycycline, ciprofloxacin, chloramphenicol,
gentamicin, cefuroxime cotrimoxazole, vancomycin,
doxycycline, oxacillin, erythromycin, augmentin, nystatin,
ketoconazole, miconazole, flucytosine and fluconazole
(Liofilchem, Roseto, Italy). The plates were incubated
aerobically at 37oC for 18 hours after which the zones of
inhibition were measured in milliliters and recorded as
previously reported.4,5 Data were analyzed using SPSS
Version 17.0 to measure differences between variables. Chi-
square test was done to assess associations. P-values <0.05
were considered statistically significant.
Results
Of the 265 participants enrolled into the study 114 were
males while 151 were females. Majority of participants were
in the age group 50 years and above (155, 58.5%) while the
least age range was less than 30 years (18, 6.8%). The overall
prevalence of ASB in this study was 33.2% (95% CI; 27.6
- 39.3). There was a significant difference in the prevalence
of ASB between diabetics and non-diabetics (38.3% vs
26.1%; P = 0.038).  Table 1 shows the distribution of  ASB
with respect to age and sex. There was no significant
difference in the distribution of ASB with age (P > 0.05)
among the study participants. However, women
demonstrated a higher prevalence than men (P < 0.001) in
both diabetic and non-diabetic groups.
The distribution of urine isolates among
study participants is presented on table 2. There was
a significant difference in the type of species isolated
from diabetics and non-diabetics (18/19 vs 8/19; P
< 0.001). The most prevalent organisms isolated were
coagulase-negative staphylococci (36.3%), Klebsiella sp
(15.9%), E. coli (10.8 %), Candida sp (13.7%) and
Serratia sp (10.8%). Comparatively, Serratia sp and
Candida sp were isolated frequently in diabetics than
in non-diabetics (P < 0.05) while Klebsiella sp was
isolated more in non-diabetics (P < 0.001). Generally,
Gram negative rods were the most common type
of organisms (45.1%) isolated from urine, followed
by Gram positive cocci (41.2%) then yeasts (13.7%).
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Table 1: Distribution of  asymptomatic bacteriuria with respect to age and sex
Age Diabetics with Non-diabetics Total with N
ASB n (%) with ASB n (%) ASB n (%)
16-30yrs 4 (22.2 %) 3 (16.7 %) 7 (38.9 %) 18
31-40yrs 4 (16.0 %) 3 (12.0 %) 7 (28.0 %) 25
41-50yrs 15 (22.4 %) 5 (7.5 %) 20 (29.9 %) 67
50+ 36 (23.2 %) 18 (11.6 %) 54 (34.8 %) 155
P =0.885 P =0.674 P =0.779
Sex
Male 8 (7.0 %) 5 (4.3 %) 13 (11.3 %) 115
Female 51 (34.0 %) 24 (16.0 %) 75 (50.0 %) 150
P <0.001 P =0.003 P <0.001
Overall 59/154 (38.3%) 29/111 (26.1%) 88/165 (33.2%) 165
 prevalence









Candida sp 12 (16.7) 2 (6.7) 14 (13.7) P = 0.01 S
Streptococcus sp 4 (5.6) 0 (0.0) 4 (3.9) P > 0.05 NS
CNS 24 (33.3) 13 (43.3) 37 (36.3) P > 0.05 NS
Staphylococcus aureus 1 (1.4) 0 (0.0) 1 (0.9) P > 0.05 NS
Citrobacter freundii 1 (1.4) 2 (6.7) 3 (2.9) P > 0.05 NS
E.coli 9 (12.5) 2 (6.7) 11 (10.8) P > 0.05 NS
Pantoea sp 2 (2.8) 0 (0.0) 2 (2.0) P > 0.05 NS
Proteus vulgaris 0 (0.0) 1 (3.3) 1 (0.9) P > 0.05 NS
Enterobacter aerogenes 2 (2.8) 0 (0.0) 2 (2.0) P > 0.05 NS
Klebsiella sp 7 (9.7) 9 (30.0) 16 (15.9) P < 0.001 S
Serratia sp 10 (13.9) 1 (3.3) 11 (10.8) P = 0.03 S









P < 0.001 S
S = Significant NS = Not significant. Percentages are calculated per column
Table 3: Antibiotic resistance of  urinary E. coli and Klebsiella sp in diabetics and non-diabetics
Antimicrobial
agent









Nalidixic acid 5 (33.3) 9 (10.3) 3 (30.0) 4 (8.0) NS
Cefuroxime 2 (13.3) 8 (9.2) 2 (20.0) 8 (16.0) NS
Doxycycline 2 (13.3) 8 (9.2) 1 (10.0) 3 (6.0) NS
Nitrofurantoin 0 (0.0) 11 (12.6) 0 (0.0) 9 (18.0) NS
Ceftriaxone 0 (0.0) 10 (11.5) 0 (0.0) 2 (4.0) NS
Ciprofloxacin 0 (0.0) 4 (7.0) 0 (0.0) 5 (10.0) NS
Chloramphenicol 0 (0.0) 12 (13.8) 0 (0.0) 8 (16.0) NS
Erythromycin 2 (13.3) 12 (13.8) 2 (20.0) 4 (8.0) NS
Gentamicin 4 (26.7) 13 (14.9) 2 (20.0) 7 (14.0) NS
*Total 15 87 10 50
P values on the table are between diabetics and non-diabetics; NS = not significant. P value antibiotic resistance between E.
coli and Klebsiella sp > 0.05      *Total number of  resistance observed within bacterial type
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Discussion
The association of diabetes mellitus and urinary tract
infections is increasingly being reported.
Asymptomatic bacteriuria is common among
diabetic patients and may lead to serious
complications if not properly managed.9 ASB has
been identified as a risk factor for acquiring
symptomatic UTIs especially in diabetic women1.
UTIs are more severe in diabetic patients involving
life-threatening complications such as
emphysematous pyelonephritis and renal papillary
necrosis9. Despite the importance of bacteriuria in
diabetics; there is paucity of  information on the
relationship between UTI and diabetes especially in
sub-Saharan Africa. Reports on the prevalence and
aetiology of  ASB appear contradictory especially in
developing countries. Therefore, the present study
was aimed to determine the prevalence and
spectrum of microorganisms responsible for
asymptomatic bacteriuria in diabetics and to
determine antimicrobial resistance of  urinary isolates.
The present study revealed an overall
prevalence of ASB of 33.2%; 38.3% in diabetics
and 26.1% in non-diabetics (table 1).  This result is
concurrent with that of earlier reports which
recorded prevalence of 36.2 % in diabetics10 and
18.5 % in non-diabetics.5 In Cameroon, high
prevalence (35.2 – 58.3 %) of bacteriuria has been
recorded.14,17 On the contrary, the prevalence of  ASB
in this study is higher than that of some studies which
recorded 5.3 - 26% in diabetics and 3.5–15% in non-
diabetics.3,4,18,19,20 Consequently, the issue of
prevalence of ASB remains debatable. This
inconsistency has been attributed to variations in
sample size, geographical location, culture or
screening method.11 In the present study, ASB was
significantly higher in diabetics than non-diabetics (P
= 0.038). This is in line with majority of previous
reports.7,12 The prevalent microorganisms (Table 2)
in the present study were coagulase negative
Staphylococcus (36.3%), Klebsiella sp (15.9%), Candida
sp (13.7%), E. coli and Serratia sp (10.8% each). This
is contrary to other studies5,7,8,9 where E. coli was the
predominant bacteria. The predominance of bacteria
other than E. coli in the urinary tract is increasingly
being reported. Recent study in Nigeria has reported
Staphylococus aureus to be the most common
uropathogen in diabetics and non-diabetics.12 The
high prevalence of Staphylococus sp in ASB may be
due to the fact that these organisms are mostly
normal skin flora and can be introduced to the
urinary tract during sexual intercourse.12 The high
prevalence of CNS could also be attributed to
inappropriate use of antibiotics which may
encourage the proliferation of highly resistant
bacteria such as CNS.21 The frequency of  isolation
of  uropathogens (Table 2) was similar among
diabetics and non-diabetics except for Candida sp
and Serratia sp which were isolated more from
diabetics than non-diabetics (P=0.01 and P=0.03,
respectively). On the contrary, Klebsiella sp was
isolated more from non-diabetics (P<0.001). The
mechanism for this difference between diabetics and
non-diabetics is not fully elucidated. However, higher
carriage rate of Candida sp has also been reported in
diabetics and this was attributed to the presence of
excess glucose in diabetics that may encourage the
growth of  Candida sp.22
Results of the antibiotic susceptibility test
revealed no significant difference (P>0.05) in the
resistant pattern between diabetics and non-diabetics
(Table 3). It was noted that nystatin; gentamicin and
ciprofloxacin were the most active ingredients against
yeasts, Gram positive and Gram negative organisms,
respectively. Generally, high resistance was observed
against oxacillin (52.8%), cotrimoxazole (64.7%),
nitrofurantoin (46.5%), Erythromycin (48.8%) and
gentamicin (59.3%) (Note: Gram negative bacteria only
showed high resistance to gentamicin). The rate and
spectrum of antibiotic resistance in this study is similar
to that of studies conducted in other developing
countries.3,4 In Cameroon, high rates of  resistance
have also been recorded among uropathogens and
the results are similar to our findings.14,15 In one of
such studies, resistance to all Gram negative isolates
was observed for amoxicillin (87%), piperacillin
(74%) and cotrimoxazole (73%); meanwhile
ofloxacine (88%) and imipenem (98%) were the most
active antibiotics.15 Resistance to penicillins is
associated with the production of beta lactamase.
High resistance to cotrimoxazole may be due its
frequent use in our study area to treat UTIs and other
infectious diseases. In the present study, Gram
negative bacteria showed high resistance to
gentamicin (59.3%) compared to Gram positive
cocci (11.8%). This difference in resistance may be
due to the over-expression of efflux pumps in Gram
negative bacteria.23 Nitrofurantoin resistance is usually
uncommon; the moderate resistance observed in this
study may be due to the development of cross-
resistance. Gram negative bacteria showed moderate
to high resistance to both the second and third
generation cephalosporins. This is commensurate to
previous reports in the study area15 as well as other
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developing countries.4 Resistance to ceftriaxone has
been attributed to Extended spectrum beta
lactamases (ESBLs) production.4 In the present study,
E. coli strains demonstrated multi-drug resistance
especially to gentamicin, nalidixic acid, doxycycline,
cefuroxime and erythromycin. Multi-drug resistance
of E. coli is a common phenomenon as reported by
other authors.5,10,18 The most resistant Gram positive
organisms were CNS. These bacteria have been
reported to show high resistance to multiple
antibiotics.21 The 15% resistance of  CNS to
gentamicin and a corresponding 22.5% resistance to
vancomycin observed in this study could be an
indication of the circulation of gentamycin-
vancomycin resistant strains in the community.
Infections with these strains are very difficult to treat
and the consequences could be fatal. Interestingly, all
S. aureus isolates were resistant to the glycopeptide
vancomycin which is commonly used to treat severe
infections caused by multi-resistant Gram positive
cocci. Our results revealed that Candida sp were highly
resistant to flucytosine. Resistance to this antimycotic
is common; that is why flucytosine is mostly used in
combination with an azole.24
Conclusion
The present study showed a high prevalence of ASB
of 38.3% in diabetes mellitus patients against 26.1%
in non-diabetics Southwest Cameroon. In addition,
it reiterates the clinical significance of CNS and
Candida sp in UTI. There was no significant difference
in the resistant pattern between diabetics and non-
diabetics.  Ciprofloxacilin was the most effective
antibiotic against most bacterial uropathogens.
Recommendation
The high prevalence of ASB and the multiple
resistances of most isolates is a major concern that
requires prompt action. Consequently, there is the
need to enhance sensitization against antibiotic abuse
so as to curb the spread of multi resistant
uropathogens in the study area.
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